Determination of the New Antiplatelet Agent Ticagrelor in Tablets by Stability-Indicating HPLC Method

Author(s): Caren Gobetti, Rubia Lazzaretti Pereira, Andreas Sebastian Loureiro Mendez, Cássia Virginia Garcia

Journal Name: Current Pharmaceutical Analysis

Volume 10 , Issue 4 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Ticagrelor is an orally active, reversibly bind of the P2Y12 receptor that can prevent ADP-mediated platelet activation and has a faster onset of action than clopidogrel. A stability-indicating HPLC method for the determination of ticagrelor in coated tablets was developed and validated. Chromatographic analysis was performed in a Shimadzu liquid chromatograph, equipped with Phemomenex® C18 column (250 x 4.6 mm, 5 μm), using a mobile phase composed of acetonitrile: water with 0.5% triethylamine (57:43 v/v) pH 7.0, at 0.7 ml/min flow rate and injection volume of 20 μl. Under the conditions established, the method demonstrated to be specific, without interference from formulation excipients, stability- indicating, linear (r = 0.9990) in the concentration range of 45.0 to 105.0 μg/ml, precise (RSD=0.71), accurate (99.61% of mean recovery) and robust. It can be successfully applied to ticagrelor tablets quality control, being adequate for routine analysis.

Keywords: Antiplatelet, HPLC, quality control, stability-indicating assay, tablets, ticagrelor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 03 September, 2014
Page: [279 - 283]
Pages: 5
DOI: 10.2174/1573412910666140610211656
Price: $65

Article Metrics

PDF: 31